Abstract: In one or more embodiments, one or more systems, methods, and/or processes may create a task configured to configure an out-of-band system of an unconfigured information handling system and discover configured information handling systems and unconfigured information handling systems that include respective out-of-band systems operable to perform the task independently of respective main processors. The one or more systems, methods, and/or processes may provide, via a network, the task to the respective out-of-band systems of the unconfigured information handling systems. In one or more embodiments, the one or more systems, methods, and/or processes may create another task configured to unconfigure the out-of-band system that was configured via the task configured to configure the out-of-band systems and may provide, via the network, the other task to at least one information handling system that was provided the task configured to configure the out-of-band system.

Abstract: A secure boot violation system includes a BIOS with an authenticated variables storage storing at least one authorization key and at least one signatures database. The BIOS receives a first policy action entry for association with a first signature in the at least one signatures database, determines that the first policy action entry is signed with the at least one authorization key and, in response, associates the first policy action entry with the first signature in the at least one signatures database. The BIOS then determines, during a boot process and subsequent to the associating the first policy action entry with the first signature, that a first secure boot violation has occurred based on the first signature in the at least one signatures database. In response to determining that the first secure boot violation has occurred, the BIOS performs a first policy action defined by the first policy action entry.

Abstract: A first device management system is assigned to have primary responsibility for management of an information handling system. A record of operating characteristics of the information handling system is maintained by a process executing at the information handling system. Primary responsibility for management of the information handling system is transitioned from the first device management system to a second device management system based on rule based analysis of the operating characteristics.

Abstract: The present invention relates to novel Chromane-Substituted Tetracyclic Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2 R3, R4 and R5 are as defined herein. The present invention also relates to compositions comprising a Chromane-Substituted Tetracyclic Compound, and methods of using the Chromane-Substituted Tetracyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: Systems and methods for tamper-proof detection triggering of automatic lockdown using a recoverable encryption mechanism issued from a secure escrow service. In an illustrative, non-limiting embodiment, an Information Handling System (IHS) may include: a processor; a secure storage device coupled to the processor, wherein the secure storage device comprises a container encrypted with a derived container key; and a memory coupled to the processor, the memory including program instructions stored thereon that, upon execution, cause the IHS to: receive a digital certificate from a remote server, wherein the digital certificate includes a public key and, in response to a detection of a tampering event, encrypt the derived container key using the public key.

Abstract: A compound of Formula (I) or (II), for treating or preventing an HCV infection in a subject.

Abstract: The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, wherein X1, X2, R1, R7, R8 and R9 are as herein described. The present invention also provides pharmaceutical compositions comprising these compounds and methods for their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.

Abstract: An information handling system includes an application processor that executes instructions of an intelligent energy management system that determines energy demand estimation based on component device utilization data from a group of client information handling systems. The information handling system includes a power policy engine that determines a timeseries power cost estimation based on the energy demand estimation, day and time of energy usage, and energy rate for the time and location.

Abstract: The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.

Abstract: Systems and methods for agentless remediation and recovery. In an illustrative, non-limiting embodiment, an Information Handling System (IHS) may include a Central Processing Unit (CPU); a Basic Input/Output System (BIOS) coupled to the CPU; a logic controller coupled to the CPU; and a memory coupled to the logic controller, the memory having program instructions stored thereon that, upon execution by the logic controller, cause the IHS to: during a first stage, check an operational state of a plurality of hardware components within the IHS in the absence of any involvement by the CPU or the BIOS; and during a second stage following the first stage, identify a failed hardware component amongst the plurality of hardware components in the absence of any involvement by the CPU or the BIOS.

Abstract: The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, Formula I or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.

Abstract: A method and system comprising a processor executing code instructions of a security filewall validation system for inspecting primitive file system operations to detect abnormal file types, abnormal file operation, or abnormal intended result files in violation of a security filewall rule set, a memory for storing the security filewall rule set describing permitted access to file types, file-paths, mounting points, data volume access rules, or data operations relating to the primitive file system operations where the security filewall validation system intercepts an attempted primitive file system operation and the security filewall validation system compares the attempted primitive file system operation including associated arguments indicating file, file location, and intended result to the security filewall rule set.

Abstract: The present invention relates to novel Silane-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A?, B, B?, R1 R2 and R3 are as defined herein. The present invention also relates to compositions comprising at least one Silane-Containing Heterocyclic Compound, and methods of using the Silane-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient.

Abstract: Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Abstract: In one or more embodiments, one or more systems, methods, and/or processes may create a task configured to configure an out-of-band system of an unconfigured information handling system and discover configured information handling systems and unconfigured information handling systems that include respective out-of-band systems operable to perform the task independently of respective main processors. The one or more systems, methods, and/or processes may provide, via a network, the task to the respective out-of-band systems of the unconfigured information handling systems. In one or more embodiments, the one or more systems, methods, and/or processes may create another task configured to unconfigure the out-of-band system that was configured via the task configured to configure the out-of-band systems and may provide, via the network, the other task to at least one information handling system that was provided the task configured to configure the out-of-band system.

Abstract: Systems and methods for agentless remediation and recovery. In an illustrative, non-limiting embodiment, an Information Handling System (IHS) may include a Central Processing Unit (CPU); a Basic Input/Output System (BIOS) coupled to the CPU; a logic controller coupled to the CPU; and a memory coupled to the logic controller, the memory having program instructions stored thereon that, upon execution by the logic controller, cause the IHS to: during a first stage, check an operational state of a plurality of hardware components within the IHS in the absence of any involvement by the CPU or the BIOS; and during a second stage following the first stage, identify a failed hardware component amongst the plurality of hardware components in the absence of any involvement by the CPU or the BIOS.

Abstract: The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.

Abstract: Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (I).

Abstract: In one or more embodiments, one or more systems, methods, and/or processes may receive, independently of a processor of the information handling system (IHS), first credential management information and may modify, independently of the processor and based on the first credential management information, credential information stored via a secure object store of the IHS. For example, modifying the credential information may include modifying the credential information such that the IHS denies access to at least a portion of the IHS based on the credential information. In one instance, denying access to at least the portion of the IHS may include disabling at least one of password, biometric information associated with a user, and an encryption key. In another instance, denying access to at least the portion of the IHS may include remapping, independently of the processor, at least one human interface device.

Abstract: In one or more embodiments, one or more systems, method, and/or processes may receive an event from an operating system and provide the event to a management controller configured to perform out-of-band tasks. The management controller may provide information based on the event to at least one subscriber. In one example, the information may include a status of an information handling system (e.g., an impairment, a hardware failure, a progress of an update, etc.). In another example, the management controller may provide information utilizing a protocol that provides a measure of reliability. For instance, the protocol may include a transmission control protocol. In one or more embodiments, the protocol may include one or more of a hypertext transfer protocol (HTTP) and a HTTP secure (HTTPS).